Trade FTH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Faeth Therapeutics, Inc. (FTH) is trading at US$20.00, down 7.02% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$826.89M. Over the past 52 weeks, FTH has traded between US$7.45 and US$42.14. On Syfe you can trade FTH with $0 commission and add it to your watchlist.
| Previous close | US$21.51 |
|---|---|
| Market cap | US$826.89M |
| 52-week range | US$7.45 – US$42.14 |
| Volume | 421.4K |
| Exchange | US |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.
Year: 2021
TD Cowen Initiates Coverage on Faeth Therapeutics With Buy Rating
Sep 9, 12:09 PM · MT Newswires
Needham Initiates Faeth Therapeutics at Buy With $56 Price Target
Aug 21, 10:23 AM · MT Newswires
Faeth Therapeutics Gets US FDA Fast Track Designation for Endometrial Cancer Drug Combination
Aug 17, 12:01 PM · MT Newswires
Faeth Therapeutics, Inc. (FTH) stock is trading at US$20.00, -7.02% from the previous close of US$21.51.
The market cap for Faeth Therapeutics, Inc. (FTH) stock is approximately US$826.89M.
The 52-week high for Faeth Therapeutics, Inc. (FTH) stock is US$42.14.
The 52-week low for Faeth Therapeutics, Inc. (FTH) stock is US$7.45.
Faeth Therapeutics, Inc. (FTH) does not currently pay a dividend.
Stay on top of FTH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
